Rockwell Medical (RMTI) Payables (2010 - 2026)

Rockwell Medical (RMTI) has reported Payables for 17 consecutive years, with $3.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Payables rose 47.04% year-over-year to $3.2 million; the trailing twelve-month figure through Jun 2026 stood at $3.2 million (up 47.04% YoY), and the FY2025 full-year result was $2.3 million, down 27.86% from the prior year.
• Payables slipped to $3.2 million in Q2 2026 per RMTI's latest filing, from $3.5 million in the prior quarter.
• Across five years, Payables topped out at $5.9 million in Q2 2023 and bottomed at $2.0 million in Q3 2025.
• Historically, Payables has averaged $3.6 million across 5 years, with a median of $3.3 million in 2026.
• The sharpest annual moves came in 2023 and 2025: Payables surged 101.46% in 2023, then plunged 59.5% in 2025.
• Over 5 years, Payables stood at $4.1 million in 2022, then advanced by 17.44% to $4.8 million in 2023, then slumped by 34.1% to $3.1 million in 2024, then fell by 27.86% to $2.3 million in 2025, then surged by 40.48% to $3.2 million in 2026.
• According to Business Quant data, Payables over the past three periods registered $3.2 million, $3.5 million, and $2.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.